Ligand Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2019	FY 2018	FY 2017	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2018 - 2019
Cash & Equivalents	1.09	0.49	0.15	0.18	0.1	Upgrade
Short-Term Investments	-	-	0.12	0.05	0.03	Upgrade
Cash & Short-Term Investments	1.09	0.49	0.26	0.22	0.13	Upgrade
Cash Growth	120.84%	86.17%	18.92%	70.77%	-51.49%	Upgrade
Accounts Receivable	5.55	7.47	2.6	3.08	2.28	Upgrade
Other Receivables	1.87	2.58	0.09	0.21	0.03	Upgrade
Receivables	7.42	10.05	2.69	3.28	2.31	Upgrade
Inventory	0.99	-	-	-	-	Upgrade
Other Current Assets	-	-	-0	-	-0	Upgrade
Total Current Assets	9.74	10.6	2.96	3.5	2.44	Upgrade
Property, Plant & Equipment	1.61	0.18	0.04	0.05	0.03	Upgrade
Long-Term Investments	0.07	0.11	0.05	0.03	0.01	Upgrade
Goodwill	0.3	-	-	-	-	Upgrade
Other Intangible Assets	0.44	0.15	0.53	0.72	0.83	Upgrade
Long-Term Deferred Charges	0.47	0	-	-	-	Upgrade
Other Long-Term Assets	1.35	2.7	0.91	0.24	0.24	Upgrade
Total Assets	13.99	13.74	4.49	4.54	3.55	Upgrade
Accounts Payable	3.2	5.52	0.67	0.88	0.89	Upgrade
Accrued Expenses	0.03	0.03	-	0.01	0.03	Upgrade
Short-Term Debt	-	-	1.22	1.1	0.75	Upgrade
Current Portion of Long-Term Debt	2.12	1.39	-	-	-	Upgrade
Current Income Taxes Payable	2	2.06	-	-	-	Upgrade
Other Current Liabilities	0.38	0.84	0.87	0.91	0.7	Upgrade
Total Current Liabilities	7.73	9.84	2.76	2.89	2.37	Upgrade
Long-Term Debt	2.89	0.55	0.3	0.1	0.16	Upgrade
Long-Term Unearned Revenue	0.11	0.31	-	-	-	Upgrade
Other Long-Term Liabilities	1.15	1.94	1.2	1.33	0.81	Upgrade
Total Liabilities	11.87	12.64	4.32	4.37	3.38	Upgrade
Common Stock	0.19	0.17	-	-	-	Upgrade
Additional Paid-In Capital	0.91	-	-	-	-	Upgrade
Retained Earnings	1.02	0.66	-	-	-	Upgrade
Comprehensive Income & Other	0.01	0.27	0.17	0.17	0.17	Upgrade
Total Common Equity	2.13	1.1	0.17	0.17	0.17	Upgrade
Minority Interest	-0.01	-	-	-	-	Upgrade
Shareholders' Equity	2.12	1.1	0.17	0.17	0.17	Upgrade
Total Liabilities & Equity	13.99	13.74	4.49	4.54	3.55	Upgrade
Total Debt	5.01	1.94	1.52	1.19	0.91	Upgrade
Net Cash (Debt)	-3.92	-1.44	-1.26	-0.97	-0.78	Upgrade
Net Cash Per Share	-0.42	-	-	-	-	Upgrade
Filing Date Shares Outstanding	9.28	-	-	-	-	Upgrade
Total Common Shares Outstanding	9.28	-	-	-	-	Upgrade
Working Capital	2.02	0.77	-	-	-	Upgrade
Book Value Per Share	0.23	-	-	-	-	Upgrade
Tangible Book Value	1.39	0.95	-	-	-	Upgrade
Tangible Book Value Per Share	0.15	-	-	-	-	Upgrade
Land	1.24	-	-	-	-	Upgrade
Machinery	0.31	0.11	-	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.